Home Prohepcidin accumulates in renal insufficiency
Article
Licensed
Unlicensed Requires Authentication

Prohepcidin accumulates in renal insufficiency

  • Youri E. C. Taes , Birgitte Wuyts , Johan R. Boelaert , An S. De Vriese and Joris R. Delanghe
Published/Copyright: June 1, 2005

Abstract

Background: The understanding of iron metabolism has increased substantially during the last decade. Several new transporters and iron regulating molecules have been described. Hepcidin, a small hepatic peptide has recently been proposed as a central mediator of dietary iron absorption. We have investigated the relationship between prohepcidin, the prohormone of hepcidin, and renal function and iron status.

Methods: Forty six patients, referred for 51Cr-EDTA clearance were included in this study. Renal function was assessed by determination of serum creatinine, creatinine clearance, serum cystatin C and serum β-trace protein. Iron status was evaluated by determination of serum iron, transferrin, transferrin saturation and serum ferritin. All determinations were performed using commercial reagents (Roche Diagnostics, Dade Behring). Serum prohepcidin was determined using an ELISA kit.

Results: Serum prohepcidin was found to correlate with 51Cr-EDTA clearance (r=−0.44; p=0.005), creatinine clearance, serum creatinine, β-trace protein and cystatin C. No significant relationship was observed between serum prohepcidin concentrations and red cell count, hemoglobin concentration or hematocrit. No significant correlation was found in this population between prohepcidin concentrations and iron status.

Conclusion: Increased serum prohepcidin concentrations were observed with declining kidney function. We observed no relationship between red cell indices or iron status and serum prohepcidin concentrations.

Published Online: 2005-6-1
Published in Print: 2004-4-5

Copyright © 2004 by Walter de Gruyter GmbH & Co. KG

Articles in the same Issue

  1. How useful are haematology analyser flags?
  2. Intravenous immunoglobulin (IVIG): modes of action in the clinical management of recurrent pregnancy loss (RPL) and selected autoimmune disorders
  3. Automated flagging influences the inconsistency and bias of band cell and atypical lymphocyte morphological differentials
  4. Extracellular concentration of homocysteine in human cell lines is influenced by specific inhibitors of cyst(e)ine transport
  5. Generation of eight adjacent mutations in a single step using a site-directed mutagenesis kit
  6. Prohepcidin accumulates in renal insufficiency
  7. Impurities from polypropylene microcentrifuge tubes as a potential source of interference in simultaneous analysis of multiple lipid-soluble antioxidants by HPLC with electrochemical detection
  8. Cerebrospinal fluid tau and Aβ42 concentrations in healthy subjects: delineation of reference intervals and their limitations
  9. The influence of smoking on plasma homocysteine and cysteine levels in passive and active smokers
  10. Reference change values and power functions
  11. A different approach to analyzing age-related HbA1c values in non-diabetic subjects
  12. Ratio of urinary free immunoglobulin light chain κ to λ in the diagnosis of Bence Jones proteinuria
  13. Influence of blood collection in plastic vs. glass evacuated serum-separator tubes on hormone and tumour marker levels
  14. Multicenter evaluation of a new immunoassay for procalcitonin measurement on the Kryptor® System
  15. Comparison of three commercial assays for the measurement of 17α-hydroxyprogesterone (17α-OHPR): limitations of the quality control system
  16. Analytical performance of the Albumin Cobalt Binding (ACB®) test on the Cobas MIRA® Plus analyzer
  17. Letter to the Editor
  18. Meetings and Awards
Downloaded on 12.9.2025 from https://www.degruyterbrill.com/document/doi/10.1515/CCLM.2004.069/html
Scroll to top button